Jeffrey Scott Sherman insider trades

Open-market stock purchases and sales by Jeffrey Scott Sherman, Chief Financial Officer at Neogenomics Inc, from SEC Form 4 filings since Feb 23, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +158%.

Recent trades

DateStockTradeValue
Feb 23, 2026NEO Neogenomics IncSold (not open market)—
Feb 23, 2026NEO Neogenomics IncBought (not open market)—
Feb 21, 2026NEO Neogenomics IncSold (not open market)—
Feb 21, 2026NEO Neogenomics IncBought (not open market)—
Dec 7, 2025NEO Neogenomics IncSold (not open market)—

Companies traded

  • NEO Neogenomics Inc: 2 buys, last Feb 23, 2026
  • PRVA Privia Health Group, Inc: other filings, last Jan 5, 2022
  • HMSY HMS Holdings Corp: 1 buy, 23 sales, last Apr 1, 2021
  • LPNT Lifepoint Hospitals, Inc: other filings, last Jul 1, 2013

Get free alerts when Jeffrey Scott Sherman files a new trade →